(1R,4R)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-ene-1-carboxylic acid, 97%, 1g

2,5-Dibromo-3,4-dimethyl-thiophene, 95%, 250mg

3,3-Difluorohexanoic acid ethyl ester (stabilised over Potassium Carbonate), 25g

Betaine Anhydrous>97.0%(T)100g

1-Chloro-4-(1,3-dibromopropyl)benzene, 95.0%, 1g

2-(ethylsulfonyl)-4-(3-methoxyphenyl)-6-(trifluoromethyl)pyrimidine, 1g

Dicaprylyl carbonate, 97%, 500g

3-Amino-5,7-dimethyladamantan-1-ol hydrochloride, 95.0%, 1g

4-(Methoxycarbonyl)tetrahydro-2H-pyran-4-carboxylic acid, 98%, 10g

N-(Pyridin-3-ylmethyl)ethanamine, 97.0%, 100g

(2R,3R,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98%, 10g

Matraces aforados clase A opaco, 250 ml, 19/26, 2 Unidad(es)

1-(Piperidin-4-yl)-1H-benzo[d]imidazole, 98%, 100mg